|
1
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta RB, Harpaz N, Itzkowitz S, et al:
Histologic inflammation is a risk factor for progression to
colorectal neoplasia in ulcerative colitis: a cohort study.
Gastroenterology. 133:1099–1105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ananthakrishnan AN, Khalili H, Konijeti
GG, et al: A prospective study of long-term intake of dietary fiber
and risk of Crohn’s disease and ulcerative colitis.
Gastroenterology. 145:970–977. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sayyed HG, Jaumdally RJ, Idriss NK, El
Sers DA and Blann A: The effect of melatonin on plasma markers of
inflammation and on expression of nuclear factor-kappa beta in
acetic acid-induced colitis in the rat. Dig Dis Sci. 58:3156–3164.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wada K, Tanaka H, Maeda K, et al: Vitamin
D receptor expression is associated with colon cancer in ulcerative
colitis. Oncol Rep. 22:1021–1025. 2009.PubMed/NCBI
|
|
6
|
Fazilleau N, Mark L, McHeyzer-Williams LJ
and McHeyzer-Williams MG: Follicular helper T cells: lineage and
location. Immunity. 30:324–335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Crotty S: Follicular helper CD4 T cells
(TFH). Annu Rev Immunol. 29:621–663. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Monteleone G, Pallone F and Macdonald TT:
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated
disease. Cytokine Growth Factor Rev. 20:185–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
King C, Tangye SG and Mackay CR: T
follicular helper (TFH) cells in normal and dysregulated immune
responses. Annu Rev Immunol. 26:741–766. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Q, Chen J, Liu Y, et al: Prevalence of
Th17 and Treg cells in gastric cancer patients and its correlation
with clinical parameters. Oncol Rep. 30:1215–1222. 2013.PubMed/NCBI
|
|
11
|
Habib T, Nelson A and Kaushansky K: IL-21:
a novel IL-2-family lymphokine that modulates B, T, and natural
killer cell responses. J Allergy Clin Immunol. 112:1033–1045. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leonard WJ and Spolski R: Interleukin-21:
a modulator of lymphoid proliferation, apoptosis and
differentiation. Nat Rev Immunol. 5:688–698. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Collins M, Whitters MJ and Young DA: IL-21
and IL-21 receptor: a new cytokine pathway modulates innate and
adaptive immunity. Immunol Res. 28:131–140. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Parrish-Novak J, Foster DC, Holly RD and
Clegg CH: Interleukin-21 and the IL-21 receptor: novel effectors of
NK and T cell responses. J Leukoc Biol. 72:856–863. 2002.PubMed/NCBI
|
|
15
|
Fina D, Caruso R, Pallone F and Monteleone
G: Interleukin-21 (IL-21) controls inflammatory pathways in the
gut. Endocr Metab Immune Disord Drug Targets. 7:288–291. 2007.
View Article : Google Scholar
|
|
16
|
Caruso R, Fina D, Peluso I, et al: A
functional role for interleukin-21 in promoting the synthesis of
the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
Gastroenterology. 132:166–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Florén CH, Benoni C and Willén R:
Histologic and colonoscopic assessment of disease extension in
ulcerative colitis. Scand J Gastroenterol. 22:459–462. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Linterman MA and Vinuesa CG: Signals that
influence T follicular helper cell differentiation and function.
Semin Immunopathol. 32:183–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morita R, Schmitt N, Bentebibel SE, et al:
Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular
cells and contain specific subsets that differentially support
antibody secretion. Immunity. 34:108–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q, Liu Z, Dang E, et al: Follicular
helper T cells (Tfh) and IL-21 involvement in the pathogenesis of
bullous pemphigoid. PLoS One. 8:e681452013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spolski R and Leonard WJ: IL-21 and T
follicular helper cells. Int Immunol. 22:7–12. 2010. View Article : Google Scholar
|
|
22
|
Yu D, Batten M, Mackay CR and King C:
Lineage specification and heterogeneity of T follicular helper
cells. Curr Opin Immunol. 21:619–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stolfi C, Pallone F, Macdonald TT and
Monteleone G: Interleukin-21 in cancer immunotherapy: Friend or
foe? Oncoimmunology. 1:351–354. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Botti E, Caruso R, Sarra M, et al: IL-21,
a new player in pathogenesis of psoriasis. Journal of Investigative
Dermatology (39th Annual Meeting of the European Society for
Dermatological Research abstracts). 129:S872009.
|
|
25
|
Rasmussen TK, Andersen T, Hvid M, et al:
Increased interleukin 21 (IL-21) and IL-23 are associated with
increased disease activity and with radiographic status in patients
with early rheumatoid arthritis. J Rheumatol. 37:2014–2020. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Spolski R, Kashyap M, Robinson C, Yu ZX
and Leonard WJ: IL-21 signaling is critical for the development of
type I diabetes in the NOD mouse. Proc Natl Acad Sci USA.
105:14028–14033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McPhee CG, Bubier JA, Sproule TJ, et al:
IL-21 is a double-edged sword in the systemic lupus
erythematosus-like disease of BXSB. Yaa mice J Immunol.
191:4581–4588. 2013. View Article : Google Scholar
|
|
28
|
Spolski R and Leonard WJ: Interleukin-21:
basic biology and implications for cancer and autoimmunity. Annu
Rev Immunol. 26:57–79. 2008. View Article : Google Scholar
|
|
29
|
Annamalai T and Selvaraj RK: Chemokine
receptor CCR7 and CXCR5 mRNA in chickens following inflammation or
vaccination. Poult Sci. 90:1695–1700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Caprioli F, Sarra M, Caruso R, et al:
Autocrine regulation of IL-21 production in human T lymphocytes. J
Immunol. 180:1800–1807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stolfi C, Rizzo A, Franzè E, et al:
Involvement of interleukin-21 in the regulation of
colitis-associated colon cancer. J Exp Med. 208:2279–2290. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hemdan NY: Anti-cancer versus
cancer-promoting effects of the interleukin-17-producing T helper
cells. Immunol Lett. 149:123–133. 2013. View Article : Google Scholar
|
|
33
|
Ysebrant de Lendonck L, Eddahri F,
Delmarcelle Y, et al: STAT3 signaling induces the differentiation
of human ICOS(+) CD4 T cells helping B lymphocytes. PLoS One.
8:e710292013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choi YS, Kageyama R, Eto D, et al: ICOS
receptor instructs T follicular helper cell versus effector cell
differentiation via induction of the transcriptional repressor
Bcl6. Immunity. 34:932–946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Akiba H, Takeda K, Kojima Y, et al: The
role of ICOS in the CXCR5+ follicular B helper T cell
maintenance in vivo. J Immunol. 175:2340–2348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bossaller L, Burger J, Draeger R, et al:
ICOS deficiency is associated with a severe reduction of CXCR5+CD4
germinal center Th cells. J Immunol. 177:4927–4932. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bauquet AT, Jin H, Paterson AM, et al: The
costimulatory molecule ICOS regulates the expression of c-Maf and
IL-21 in the development of follicular T helper cells and TH-17
cells. Nat Immunol. 10:167–175. 2009. View
Article : Google Scholar :
|
|
38
|
Galicia G, Kasran A, Uyttenhove C, De
Swert K, Van Snick J and Ceuppens JL: ICOS deficiency results in
exacerbated IL-17 mediated experimental autoimmune
encephalomyelitis. J Clin Immunol. 29:426–433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bauquet AT, Jin HL, Paterson AM, et al:
The costimulatory molecule ICOS regulates the expression of c-Maf
and IL-21 in the development of follicular T helper cells and TH-17
cells. Nat Immunol. 10:167–175. 2009. View
Article : Google Scholar :
|
|
40
|
Spolski R and Leonard WJ: IL-21 and T
follicular helper cells. Int Immunol. 22:7–12. 2010. View Article : Google Scholar
|
|
41
|
Awasthi A and Kuchroo VK: The yin and yang
of follicular helper T cells. Science. 325:953–955. 2009.PubMed/NCBI
|
|
42
|
Choi YS, Kageyama R, Eto D, et al: ICOS
receptor instructs T follicular helper cell versus effector cell
differentiation via induction of the transcriptional repressor
BcI6. Immunity. 34:932–946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kroenke MA, Eto D, Locci M, et al: Bcl6
and Maf cooperate to instruct human follicular helper CD4 T cell
differentiation. J Immunol. 188:3734–3744. 2012. View Article : Google Scholar : PubMed/NCBI
|
